指南与共识重症综合管理与镇静镇痛儿科与产科急症心脑血管急症

儿童重症监护输血与贫血专家倡议:获得性与先天性心脏病婴幼儿红细胞输注建议

Recommendations on RBC Transfusion in Infants and Children With Acquired and Congenital Heart Disease From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
指南 / 共识 · Pediatr Crit Care Med · 2018-01-01
一句话结论儿童重症监护输血与贫血专家倡议(38位国际专家)发布21条推荐:心肌功能障碍和/或肺动脉高压患儿血红蛋白>10 g/dL输血无证据获益,未矫正心脏病维持血红蛋白>7-9.0 g/dL,稳定双心室修复术后血红蛋白>7.0 g/dL不输血。

该共识由儿童重症监护输血与贫血专家倡议组织38位国际多学科专家制定,针对危重心脏病患儿红细胞输注提出21条推荐并达成一致。心脏疾病亚组由3位专家负责,检索1980年至2017年5月PubMed、EMBASE和Cochrane Library数据库,采用Research and Development/UCLA适当性方法达成一致,并以GRADE方法总结证据。推荐指出:心肌功能障碍和/或肺动脉高压患儿血红蛋白>10 g/dL输血无证据获益;未矫正心脏病患儿依据心肺储备维持血红蛋白>7-9.0 g/dL;稳定双心室修复术后血红蛋白>7.0 g/dL不输血;稳定血流动力学的分期姑息手术婴儿血红蛋白>9.0 g/dL时避免仅依据血红蛋白输血;推荐术中及术后血液保护措施;支持短储存期红细胞的证据不足。

要点

  • 心肌功能障碍和/或肺动脉高压患儿:无证据表明血红蛋白>10 g/dL时输血有益。
  • 未矫正心脏病患儿:推荐依据心肺储备维持血红蛋白>7-9.0 g/dL。
  • 稳定双心室修复术后患儿:推荐血红蛋白>7.0 g/dL时不输血。
  • 稳定血流动力学的分期姑息手术婴儿:推荐血红蛋白>9.0 g/dL时避免仅依据血红蛋白输血。
  • 推荐术中及术后血液保护措施;支持短储存期红细胞的证据不足。

适用人群与场景

  • 危重心脏病患儿,包括获得性与先天性心脏病。
  • 心脏疾病亚组包括心肌功能障碍和/或肺动脉高压患儿、未矫正心脏病患儿、接受双心室修复的稳定患儿、接受分期姑息手术且血流动力学稳定的婴儿。

处置流程与药物剂量

  • 心肌功能障碍和/或肺动脉高压患儿:无证据表明血红蛋白>10 g/dL时输血有益。
  • 未矫正心脏病患儿:推荐依据心肺储备维持血红蛋白>7-9.0 g/dL。
  • 稳定双心室修复术后患儿:推荐血红蛋白>7.0 g/dL时不输血。
  • 稳定血流动力学的分期姑息手术婴儿:推荐血红蛋白>9.0 g/dL时避免仅依据血红蛋白输血。
  • 推荐术中及术后血液保护措施。

研究设计与关键结果

  • 共识会议系列由38位国际多学科儿童红细胞输注管理专家参与,其中心脏疾病亚组包括3位专家。
  • 检索PubMed、EMBASE和Cochrane Library数据库1980年至2017年5月,采用Research and Development/UCLA适当性方法达成一致,并以GRADE方法总结结果。
  • 共制定21条推荐并达成一致。
  • 心肌功能障碍和/或肺动脉高压患儿:无证据表明血红蛋白>10 g/dL时输血有益。
  • 未矫正心脏病患儿:推荐依据心肺储备维持血红蛋白>7-9.0 g/dL。
  • 稳定双心室修复术后患儿:推荐血红蛋白>7.0 g/dL时不输血。
  • 稳定血流动力学的分期姑息手术婴儿:推荐血红蛋白>9.0 g/dL时避免仅依据血红蛋白输血。
  • 推荐术中及术后血液保护措施;支持短储存期红细胞的证据不足。

证据类型、等级与局限

  • 证据类型:共识会议系列(指南/共识),采用GRADE方法总结证据。
  • 局限:支持短储存期红细胞的证据不足;心脏病患儿红细胞输注的风险与获益需进一步研究。

对床旁实践的改变

  • 心肌功能障碍和/或肺动脉高压患儿血红蛋白>10 g/dL时输血无证据获益。
  • 未矫正心脏病患儿依据心肺储备维持血红蛋白>7-9.0 g/dL。
  • 稳定双心室修复术后患儿血红蛋白>7.0 g/dL时不输血。
  • 稳定血流动力学的分期姑息手术婴儿血红蛋白>9.0 g/dL时避免仅依据血红蛋白输血。
  • 推荐术中及术后血液保护措施。

指南或共识出处

  • Pediatric Critical Care Transfusion and Anemia Expertise Initiative(儿童重症监护输血与贫血专家倡议)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To present the recommendations and supporting literature for RBC transfusions in critically ill children with acquired and congenital heart disease developed by the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

DESIGN: Consensus conference series of 38 international, multidisciplinary experts in RBC transfusion management of critically ill children.

METHODS: Experts developed evidence-based and, when evidence was lacking, expert-based clinical recommendations and research priorities for RBC transfusions in critically ill children. The cardiac disease subgroup included three experts. Electronic searches were conducted using PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017. Agreement was obtained using the Research and Development/UCLA appropriateness method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method.

RESULTS: Twenty-one recommendations were developed and reached agreement. For children with myocardial dysfunction and/or pulmonary hypertension, there is no evidence that transfusion greater than hemoglobin of 10 g/dL is beneficial. For children with uncorrected heart disease, we recommended maintaining hemoglobin greater than 7-9.0 g/dL depending upon their cardiopulmonary reserve. For stable children undergoing biventricular repairs, we recommend not transfusing if the hemoglobin is greater than 7.0 g/dL. For infants undergoing staged palliative procedures with stable hemodynamics, we recommend avoiding transfusions solely based upon hemoglobin, if hemoglobin is greater than 9.0 g/dL. We recommend intraoperative and postoperative blood conservation measures. There are insufficient data supporting shorter storage duration RBCs. The risks and benefits of RBC transfusions in children with cardiac disease requires further study.

CONCLUSIONS: We present RBC transfusion management recommendations for the critically ill child with cardiac disease. Clinical recommendations emphasize relevant hemoglobin thresholds, and research recommendations emphasize need for further understanding of physiologic and hemoglobin thresholds and alternatives to RBC transfusion in subpopulations lacking pediatric literature.

来源:Pediatr Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Cholette JM, Willems A, Valentine SL, et al. Recommendations on RBC Transfusion in Infants and Children With Acquired and Congenital Heart Disease From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018. PMID: 30161069. doi:10.1097/PCC.0000000000001603

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。